Formulary evolution An updated look at the world of formularies Sep 1, 2006 By: Tony Pinsonault

Formularies, like managed care in general, are in a constant state of evolution.

Medicare Part D Update Eight ways to penetrate the over -65 market Dec 1, 2007 By: Tony Pinsonault

The implementation of the new Medicare Part D prescription-drug benefit in 2006 helped create a "perfect storm" for U.S. pharmaceutical and biotechnology manufacturers.

Open and closed The case for a new understanding of formularies May 1, 2007 By: Bill Barr

Formularies are often described using terms such as "open," meaning all products are available, and "closed," meaning that only certain products are available. However, given the complex nature of pharmacy-benefit design, these terms are inadequate as labels to describe formularies.

Access: Restricted Selling pharmaceuticals under the Physician Data Restriction Program Feb 1, 2007 By: Gwen McLean

Your ability to view prescribing data is minimal.

Pass the buck Do you know who pays for your products? Jan 1, 2007 By: Bill Barr

To maximize sales in a managed care environment, pharmaceutical representatives must identify the "true payers" who assume the financial risk for their products.

What you need to know now that Part D is reality.

Payday The way physicians are compensated can influence prescribing Mar 1, 2006 By: Christian Pinsonault, Tony Pinsonault

When reps understand how physicians are paid, they gain insights into how financial factors influence prescribing behavior. Then they can fine-tune their messages to help address physician needs while ensuring appropriate utilization of their products.

Beyond the doughnut hole What you need to know about the new Medicare Part D benefit plans Dec 1, 2005 By: Tony Pinsonault, Christian Pinsonault

What you need to know about the new Medicare Part D benefit plans.

A Q&A with Richard Stefanacci.